Heated Humidified Breathing Circuit Rewarming in Hypothermic Patients Post Cardiopulmonary Bypass – Pilot Study

Author(s):  
Benjamin H Brockbank ◽  
Mary Cooter Wright ◽  
Jhaymie C ◽  
Brittany A Zwischenberger ◽  
Ian J Welsby ◽  
...  
Perfusion ◽  
2007 ◽  
Vol 22 (1) ◽  
pp. 57-61 ◽  
Author(s):  
WW Yap ◽  
D. Young ◽  
V. Pathi

Perioperative volume replacement after cardiopulmonary bypass is complicated by post-bypass systemic inflammatory process. The aim of this study was to assess the effects of using two different colloid solutions as priming fluids in cardiopulmonary bypass. The study's primary end point was to measure the amount of fluid replacement needed during and post-cardiopulmonary bypass; blood loss, change in blood profile and intraocular pressure were secondary end points, used as measures of plasma oncotic pressures. Patients undergoing coronary artery bypass grafting were recruited. Both patients and surgeons were blinded to receive either Gelofusine® or Voluven® as priming fluids. At fixed intervals during cardiopulmonary bypass, the patients had their intraocular pressures measured. Intra and postoperative fluid replacement was in the form of 4.5% human albumin and the amount was recorded for each subject. The result did not show any significant differences in the amount of fluid needed to be replaced, in blood loss or in blood profile between the two groups. However, it showed an increase in intraocular pressure in both groups once cardiopulmonary bypass commenced. The average intraocular pressure was higher in the Gelofusine ® group compared to the Voluven® group. The significant increase in intraocular pressure measurements in the Gelofusine® group compared to the Voluven® group support the hypothesis that Voluven maintains the plasma oncotic pressure better and reduces fluid shift. Perfusion (2007) 22, 57—62.


Perfusion ◽  
2020 ◽  
Vol 35 (8) ◽  
pp. 826-832
Author(s):  
Tomomi Hasegawa ◽  
Yoshihiro Oshima ◽  
Shinji Yokoyama ◽  
Asuka Akimoto ◽  
Yusuke Misaka ◽  
...  

Objective: The use of biocompatible materials to reduce the systemic activation of inflammation and coagulation pathways is expanding rapidly. However, there have been few clinical studies of biocompatible circuits for pediatric cardiopulmonary bypass. This pilot study aimed to preliminarily evaluate the biocompatibility of SEC-1 coat™ (SEC) for cardiopulmonary bypass circuits in pediatric cardiac surgery. Methods: Twenty infants undergoing cardiac surgery for isolated ventricular septal defects at Kobe Children’s Hospital were assigned randomly to an SEC-coated (SEC group, n = 10) or heparin-coated (control group, n = 10) circuit. Perioperative data and the following markers were prospectively analyzed: platelet counts and interleukin-6, interleukin-8, C3a, β-thromboglobulin, and thrombin–antithrombin complex levels. Results: Neither patient characteristics nor postoperative clinical outcomes differed significantly between the SEC and control groups. Platelet counts markedly decreased during cardiopulmonary bypass in both groups, but were significantly better preserved in the SEC group. Fewer patients needed postoperative platelet transfusions in the SEC group. After cardiopulmonary bypass termination, serum levels of β-thromboglobulin and thrombin–antithrombin complex were significantly lower in the SEC than in the control group. Although the differences were not statistically significant, serum levels of interleukin-6, interleukin-8, and C3a had a tendency toward being lower in the SEC group, with good preservation of leukocyte counts, fibrinogen, and antithrombin III. Conclusion: SEC-1 coat™ for cardiopulmonary bypass circuits have good biocompatibility with regard to platelet preservation and in terms of attenuating inflammatory reaction or coagulation activation during pediatric cardiac surgery. It can be beneficial in pediatric as well as adult cardiac surgery.


Perfusion ◽  
2016 ◽  
Vol 31 (6) ◽  
pp. 508-515 ◽  
Author(s):  
Michael Mazzeffi ◽  
Lindsey Lund ◽  
Karin Wallace ◽  
Anthony V Herrera ◽  
Kenichi Tanaka ◽  
...  

1989 ◽  
Vol 47 (2) ◽  
pp. 297-299 ◽  
Author(s):  
Ronald S. Chung ◽  
Donald J. Magilligan ◽  
R.Roy Eisiminger ◽  
Michael A. Fried ◽  
Janet A. Serwatowski ◽  
...  

2011 ◽  
Vol 167 (2) ◽  
pp. e77-e83 ◽  
Author(s):  
Yin Kai Chao ◽  
Yi Cheng Wu ◽  
Kun Ju Yang ◽  
Ling Ling Chiang ◽  
Hui Ping Liu ◽  
...  

2001 ◽  
Vol 42 (4) ◽  
pp. 425-433 ◽  
Author(s):  
Shyamal Premaratne ◽  
Aziz M Razzuk ◽  
Deepthi R Premaratne ◽  
Mark M Mugiishi ◽  
Nahidh W Hasaniya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document